This study was aimed to analyze how human capital, work engagement, and work-life balance affect work productivity as mediated by work discipline. This study used a quantitative method on 178 respondents from PT Widodo Unggas employees. Data analysis using the SEM-PLS technique with a path analysis approach and the correlation test. According to the findings of this study, human capital and work-life balance have an impact on employee work discipline, while work engagement has no impact on work discipline. Productivity is affected by human capital, work engagement, and work-life balance. This research also confirmed that work discipline also has an impact on productivity.

Severe acute respiratory syndrome coronavirus 2 that causes coronavirus disease 2019 (COVID-19) is changing at a rapid pace due to accumulated mutations in the viral genetic code over time. As new variants of the virus continue to emerge and replace previous versions of the variants, therapeutics and vaccines are being constantly monitored and reviewed for their efficacy against the new strains. With the surge in new omicron sub-variants across the nation, U.S. Food and Drug Administration issued emergency use authorization to a new monoclonal antibody therapy called bebtelovimab replacing the previous sotrovimab that was effective against Omicron BA.1. The main objective of the paper is to review the current treatment options available to treat non-hospitalized mild-to-moderate COVID-19 caused by the new omicron sub-variants BA.2, BA.4, and BA.5. Scientists, pharmaceutical companies, and researchers have been proactive in conducting randomized, double-blinded, placebo-controlled clinical trials to test the safety and efficacy of therapeutics in managing COVID-19 in addition to testing the vaccine efficacy against new strains. The paper focuses on reviewing the results of these randomized controlled trials. The oral antiviral options paxlovid and molnupiravir, and intravenous (IV) bebtelovimab continue to show their efficacy against the new sub-variants BA.4 and BA.5. It is important for everyone to stay well-informed of the new treatment options and only opt for those medications that are currently authorized for use in treating mild-to-moderate COVID-19.

In recent years, studies have placed a greater emphasis on the scientific evaluation of historical plant-based medications, as well as the examination of various plant parts for medicinal and pharmacological significance. In light of cultural histories and ancient medicine from previous decades, which have continued to promote the healing benefits of plants and their extracts, the medicinal values of plants cannot be overstated. Nutraceuticals are the use of therapeutic properties of plants or plant parts to prevent and control illness. The Zingiberaceae family includes Curcuma longa (Turmeric), which is one of the most innovative nutraceuticals. It is widely grown and consumed in India and Asian countries as a shelf-life enhancer and preservative, aromatic, and coloring ingredient. It possesses anti-glycemic, antioxidant, anti-inflammatory, anti-carcinogenic, and anti-viral properties, among other health advantages. For millennia, Curcuma longa has been regarded safe to use as a spice and seasoning.